NCT00724542
Unknown
Not Applicable
Evaluation of Lifestyle and Therapeutic Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease.
Ministry of Science and Technology of the People´s Republic of China1 site in 1 country1,600 target enrollmentJuly 2008
InterventionsVoglibose tablets
DrugsVoglibose tablets
Overview
- Phase
- Not Applicable
- Intervention
- Voglibose tablets
- Conditions
- Coronary Heart Disease
- Sponsor
- Ministry of Science and Technology of the People´s Republic of China
- Enrollment
- 1600
- Locations
- 1
- Primary Endpoint
- TypeⅡDiabetes Mellitus
- Last Updated
- 17 years ago
Overview
Brief Summary
The purpose of this study is to determine whether therapeutic intervention on impaired glucose tolerance in patients with coronary heart disease can decrease the incidence of new onset DM.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with coronary heart disease
- •Impaired Glucose Tolerance
Exclusion Criteria
- •Age \< 40yr or \> 75yr
- •Diabetes Mellitus
- •Scr \> 2.0 mg/dL（176 μmol/L）
- •ALT or AST \> 2.5 ULN
- •Hb \< 90g/L
- •Heart Failure
- •Infection
- •Undergo other interventional clinical trial
Arms & Interventions
Drug
Voglibose tablets with lifestyle intervention
Intervention: Voglibose tablets
Outcomes
Primary Outcomes
TypeⅡDiabetes Mellitus
Time Frame: 2 years
Secondary Outcomes
- Occurrence of Cardiovascular Events(2 years)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Lifestyle Intervention for Treatment of DiabetesType 2 DiabetesOverweightObesityNCT01806727Wake Forest University260
Completed
Phase 4
Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)HypertensionMetabolic SyndromeNCT00234858Abbott280
Recruiting
Not Applicable
Lifestyle Patterns and Glycemic ControlPre-diabetesNCT05224986Columbia University34
Unknown
Not Applicable
Lifestyle Intervention Treatment for Patients With Mild Obstructive Sleep ApneaObstructive Sleep ApneaNCT00486746Kuopio University Hospital81
Completed
Phase 2
Lifestyle Intervention to Improve Insulin Sensitivity and Markers of Cardiovascular Risk in Prostate Cancer SurvivorsProstate CancerNCT00738140Massachusetts General Hospital15